01:13 PM EDT, 05/15/2024 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) shares were up nearly 20% in recent trading after the company reported in regulatory filings Wednesday that several of its executives purchased shares in the company earlier in the week.

According to the filings, Chief Executive Jon Stonehouse and Chief Commercial Officer Charles Gayer each acquired 30,000 shares on Monday, while Chief Legal Officer Alane Barnes acquired 5,000 shares.

The filings also show Chief Financial Officer Anthony Doyle and Chief R&D Officer Helen Thackray on Tuesday acquired 36,300 and 30,000, respectively.

Price: 6.32, Change: +0.96, Percent Change: +17.82